In conclusion, the results of this study point to estradiol levels as a major factor in determining the BMD values in postmenopausal women.doi:10.1805/UnivMed.2010.v29.90-95Martiem MawiUniversa MedicinaMawie M. Serum estradiol level and bone mineral density in postmenopausal women. Univ Med 2010...
Use of estrogens alone in postmenopausal women generally is referred to as estrogen replacement therapy (ERT); use of estrogens in combination with progestins usually is referred to as hormone replacement therapy (HRT) or postmenopausal hormone therapy....
Estradiol Supplementation in Postmenopausal Women Attenuates Suppression of Pulsatile Growth Hormone Secretion by Recombinant Human Insulin-like Growth Fac... Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor...
If these results wind up being replicated in a large sample of postmenopausal women not at risk for dementia, estradiol-based hormone therapy could become more broadly a treatment of choice to preserve optimal brain aging, she said.
Six normolipidemic (plasma cholesterol, 5.63 +/- 0.83 mmol/L; plasma triglycerides, 1.47 +/- 0.69 mmol/L) postmenopausal women (amenorrhea > 1 yr; aged 55.5 +/- 4.0 yr) received an oral fat load (50 g/m2 fat as cream, with 60,000 IU RP/m2) before and after 6 weeks of 17 ...
An estrogenic hormone, C18H24O2, that is produced by the ovaries and is the dominant naturally occurring estrogen in women between puberty and menopause. It is used to treat menopausal symptoms and other conditions. [estra-,estrogenic hormone(fromestrus) +di-+-ol.] ...
We expected to observe a symptom increase from the early luteal to the perimenstrual phase under PBO that would be prevented in the EP condition. In statistical terms, we predicted an interaction of experimental condition (at level 2) with cycle phase contrast (between early luteal and peri...
Women with both higher E2 and hs-CRP (defined as values into the upper tertile) had an age-adjusted OR of 4.2 (95% CI, 1.7-10.5; P = 0.002), compared with women with low levels of both E2 and hs-CRP. CONCLUSION: Higher E2 levels were associated with frailty in postmenopausal women...
In postmenopausal women, a significant proportion of the circulating estrogens exist as sulfate conjugates, especially estrone sulfate, which serves as a circulating reservoir for the formation of more active estrogens. Excretion Estradiol, estrone, and estriol are excreted in the urine along with ...
METHODS Fifteen postmenopausal women with variant angina (mean age 54.2 years) were given a hyperventilation (HV) test, a provocation test for coronary spasm, in the early morning of day 1 (baseline), day 3 (after 2-day transdermal E2 supplementation, 4 mg) and day 5 (after 2-day ...